药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
3-Methylfentanyl
Dixyrazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Dixyrazine.
3-Methylfentanyl
Thiazinam
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Thiazinam.
3-Methylfentanyl
Chlorproethazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Chlorproethazine.
3-Methylfentanyl
Butaperazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Butaperazine.
3-Methylfentanyl
Perazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Perazine.
3-Methylfentanyl
Propiopromazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Propiopromazine.
3-Methylfentanyl
Cyamemazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Cyamemazine.
3-Methylfentanyl
BL-1020
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with BL-1020.
3-Methylfentanyl
Thioproperazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Thioproperazine.
3-Methylfentanyl
Aceprometazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Aceprometazine.
3-Methylfentanyl
Acepromazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Acepromazine.
3-Methylfentanyl
Periciazine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Periciazine.
3-Methylfentanyl
Tofacitinib
Tetrandrine may increase the immunosuppressive activities of Tofacitinib.
3-Methylfentanyl
Lithium hydroxide
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Lithium hydroxide.
3-Methylfentanyl
Lithium carbonate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Lithium carbonate.
3-Methylfentanyl
Lithium citrate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Lithium citrate.
3-Methylfentanyl
Lumefantrine
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Lumefantrine.
3-Methylfentanyl
Artemether
The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Artemether.
3-Methylfentanyl
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Tetrandrine.
3-Methylfentanyl
Ivabradine
Tetrandrine may increase the bradycardic activities of Ivabradine.